Context Therapeutics (CNTX) vs Immutep (IMMP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Immutep (IMMP) has outperformed Context Therapeutics (CNTX) over the past year, gaining 95.2% versus a loss of 72.3%. Immutep is the larger company by market cap ($28.4 million vs $28.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNTX | IMMP |
|---|---|---|
| Share price | $0.3068 | $3.86 |
| Market cap | $28.19M | $28.44M |
| 1-day change | -1.86% | -6.07% |
| YTD return | -78.73% | +41.96% |
| 1-year return | -72.34% | +95.19% |
| 5-year return | — | +2.78% |
| EPS (TTM) | $-0.48 | $-7.30 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.62 | $70.60 |
| 52-week low | $0.297 | $3.80 |
| Distance from 52-week high | -91.52% | -94.53% |
| Average volume | 1.83M | 14.70K |
| Shares outstanding | 91.88M | 7.37M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IMMP has outperformed CNTX by 167.5 percentage points over the past year.
CNTX vs IMMP FAQ
Which is bigger, Context Therapeutics or Immutep?
Immutep (IMMP) is larger, with a market capitalization of $28.44M compared with $28.19M for Context Therapeutics (CNTX).
Which stock has performed better over the past year, CNTX or IMMP?
IMMP returned +95.19% over the past 12 months, compared with -72.34% for CNTX (price return, excluding dividends). Past performance does not predict future results.
Are Context Therapeutics and Immutep in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.